Poland
· Delayed Price · Currency is PLN Krynica Vitamin Statistics
Total Valuation
Krynica Vitamin has a market cap or net worth of PLN 123.74 million. The enterprise value is 161.72 million.
| Market Cap | 123.74M |
| Enterprise Value | 161.72M |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Krynica Vitamin has 12.25 million shares outstanding. The number of shares has decreased by -0.17% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 12.25M |
| Shares Change (YoY) | -0.17% |
| Shares Change (QoQ) | -0.71% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 1.92% |
| Float | 1.61M |
Valuation Ratios
The trailing PE ratio is 10.10.
| PE Ratio | 10.10 |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 1.33 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 3.99 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.22 |
| EV / Sales | 0.42 |
| EV / EBITDA | 5.26 |
| EV / EBIT | 9.62 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 1.36 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.97% and return on invested capital (ROIC) is 7.44%.
| Return on Equity (ROE) | 13.97% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.44% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.15M |
| Profits Per Employee | 36,402 |
| Employee Count | 336 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.79% in the last 52 weeks. The beta is -0.50, so Krynica Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | -0.50 |
| 52-Week Price Change | -8.79% |
| 50-Day Moving Average | 9.05 |
| 200-Day Moving Average | 9.66 |
| Relative Strength Index (RSI) | 76.51 |
| Average Volume (20 Days) | 753 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Krynica Vitamin had revenue of PLN 387.89 million and earned 12.23 million in profits. Earnings per share was 1.00.
| Revenue | 387.89M |
| Gross Profit | 16.81M |
| Operating Income | 16.81M |
| Pretax Income | 13.81M |
| Net Income | 12.23M |
| EBITDA | 30.76M |
| EBIT | 16.81M |
| Earnings Per Share (EPS) | 1.00 |
Balance Sheet
The company has 3.95 million in cash and 41.93 million in debt, giving a net cash position of -37.98 million or -3.10 per share.
| Cash & Cash Equivalents | 3.95M |
| Total Debt | 41.93M |
| Net Cash | -37.98M |
| Net Cash Per Share | -3.10 |
| Equity (Book Value) | 93.32M |
| Book Value Per Share | 7.62 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | 31.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 4.33%, with operating and profit margins of 4.33% and 3.15%.
| Gross Margin | 4.33% |
| Operating Margin | 4.33% |
| Pretax Margin | 3.56% |
| Profit Margin | 3.15% |
| EBITDA Margin | 7.93% |
| EBIT Margin | 4.33% |
| FCF Margin | n/a |
Dividends & Yields
Krynica Vitamin does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.17% |
| Shareholder Yield | 0.17% |
| Earnings Yield | 9.88% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |